Mabion has announced a 1.5 billion zloty contract with US firm Novavax.
Mabion
Polish biotech firm strikes deal to produce Novavax Covid vaccines in Poland
Mabion’s founder said the deal was “the first step” for vaccine production in Poland.
We can only do this thanks to your support!
We are an independent, nonprofit media outlet, funded through the support of our readers.
If you appreciate the work we do, please consider helping us to continue and expand it.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
